EI
ZBH icon

Ethic Inc’s Zimmer Biomet ZBH Stock Holding History

Ethic Inc’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.31M Buy
15,256
+112
+0.7% +$9.82K 0.02% 641
2026
Q1 		$1.37M Buy
15,144
+760
+5% +$69.7K 0.02% 564
2025
Q4 		$1.29M Buy
14,384
+343
+2% +$32.5K 0.02% 565
2025
Q3 		$1.38M Buy
14,041
+7,833
+126% +$776K 0.02% 542
2025
Q2 		$568K Sell
6,208
-527
-8% -$51K 0.01% 772
2025
Q1 		$757K Sell
6,735
-10,240
-60% -$1.1M 0.02% 661
2024
Q4 		$1.79M Sell
16,975
-3,521
-17% -$378K 0.04% 436
2024
Q3 		$2.71M Sell
20,496
-2,851
-12% -$311K 0.07% 321
2024
Q2 		$2.53M Buy
23,347
+2,851
+14% +$336K 0.06% 323
2024
Q1 		$2.71M Buy
20,496
+2,798
+16% +$350K 0.07% 321
2023
Q4 		$2.15M Buy
17,698
+907
+5% +$101K 0.06% 337
2023
Q3 		$1.88M Buy
16,791
+3,797
+29% +$482K 0.07% 333
2023
Q2 		$1.89M Buy
12,994
+558
+4% +$75.8K 0.07% 319
2023
Q1 		$1.61M Buy
12,436
+600
+5% +$75.3K 0.07% 333
2022
Q4 		$1.51M Buy
11,836
+5,346
+82% +$620K 0.08% 293
2022
Q3 		$679K Sell
6,490
-5,413
-45% -$594K 0.05% 420
2022
Q2 		$1.25M Buy
11,903
+350
+3% +$41.5K 0.09% 274
2022
Q1 		$1.48M Buy
11,553
+1,140
+11% +$137K 0.1% 252
2021
Q4 		$1.28M Buy
10,413
+8,482
+439% +$1.11M 0.1% 238
2021
Q3 		$274K Sell
1,931
-404
-17% -$59.4K 0.03% 503
2021
Q2 		$365K Sell
2,335
-13
-0.6% -$2.11K 0.04% 408
2021
Q1 		$365K Sell
2,348
-816
-26% -$126K 0.07% 339
2020
Q4 		$473K Buy
3,164
+848
+37% +$120K 0.13% 222
2020
Q3 		$306K Buy
2,316
+77
+3% +$10.1K 0.12% 218
2020
Q2 		$259K Buy
+2,239
New +$258K 0.15% 198

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ethic Inc's ZBH Position: Q2 2026 in Review

Ethic Inc increased its Zimmer Biomet (ZBH) stake by 0.74% in Q2 2026, buying an estimated $9.82K and bringing the position to 15,256 shares worth $1.31M. The position accounts for 0.02% of the portfolio, ranked #641.

Ethic Inc first reported a position in ZBH in Q2 2020 and has held it in 25 quarters since. The position peaked at $2.71M in Q3 2024. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Ethic Inc held 15,256 shares of Zimmer Biomet worth $1.31M as of Q2 2026.
  • Ethic Inc bought 112 Zimmer Biomet shares in Q2 2026, an estimated $9.82K.
  • Zimmer Biomet made up 0.02% of Ethic Inc's portfolio in Q2 2026, its #641 holding.
  • Ethic Inc first reported a position in Zimmer Biomet in Q2 2020 and has held it in 25 quarters since.
  • Ethic Inc's Zimmer Biomet position peaked at $2.71M in Q3 2024.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.